Abstract
Osteocytic potentiality of human CD34+ stem cells explored in the present study by generating in vitro agarose gel 3D model to understand the bone ossification process. The G-CSF and IL-3 mobilized human CD34+ stem cells isolated apheretically from donor peripheral blood and purity of the cells was assessed by FACS and immunocytochemical (ICC) studies. The CD34+ stem cells were cultured in gel based 3D model with osteogenic stimulating medium for 21 days. The transition stages from undifferentiated to differentiated osteocytes through osteoblasts were studied with expression markers Differentiated cells at Day 7 showed positive reactivity with monoclonal anti-Runx2, an early osteoblastic marker. qPCR expression analysis showed early and mature osteoblastic markers like RUNX2, Osterix, RANKL, along with osteocyte markers SPARC, Sclerostin. While poor expression of OSCAR genes was observed apart from conspicuous expression of alkaline phosphatase. The expression of sclerostin and SPARC suggests that these differentiated cells are behaving like true osteocytes, sclerostin expression causes transformation of osteoblast into osteocytes and negligible expression of OSCAR, RANK, NFATc and cathepsin K genes explains there are no osteoclasts in the differentiated culture. These cells showed positive reaction with Alizarin red stain indicating expression of calcium bound bone morphogenic proteins like osteonectin. All these results clearly confirm the human CD34+ stem cells possess unique osteogenic differentiation potential and can be used in the early regeneration of injured bone.
Graphical abstract
Similar content being viewed by others
Abbreviations
- ALP:
-
Alkaline phosphatase
- CD34+ :
-
Cluster of Differentiation 34
- OSCAR:
-
Osteoclast-associated immunoglobulin-like receptor
- OPG:
-
Osteoprotegerin
- RUNX2:
-
Runt-related transcription factor 2
- RANKL:
-
Receptor activator of nuclear factor kappa-B ligand
- SPARC:
-
Secreted Protein Acidic and Rich in Cysteine
References
Rickard DJ, Kassem M, Hefferan TE, Sarkar G, Spelsberg TC, Riggs BL (1996) Isolation and characterization of osteoblast precursor cells from human bone marrow. J Bone Miner Res 11:312–324
Simmons PJ, Torok-Storb B (1991) CD34 expression by stromal precursors in normal human adult bone marrow. Blood 78:2848–2853
Chen JL, Hunt P, McElvain M, Black T, Kaufman S, Choi ES (1997) Osteoblast precursor cells are found in CD34+cells from human bone marrow. Stem Cells 15:368–377
Lian JB, Stein GS, Aubin JE (2003) Bone formation: maturation and functional activities of osteoblast lineage cells. In: Favus MJ (ed) Primer on the metabolic bone diseases and disorders of mineral metabolism. American Society for Bone and Mineral Research, Washington, DC, pp 13–28
Martin TJ, Ng KW (1994) Mechanisms by which cells of the osteoblast lineage control osteoclast formation and activity. J Cell Biochem 56:357–366
Papay FA, Morales L Jr, Ahmed OF, Neth D, Reger S, Zins J (1996) Comparison of ossification of demineralized bone, hydroxyapatite, Gelfoam, and bone wax in cranial defect repair. J Craniofac Surg 7:347–351
Sarma PV, Subramanyam G (2008) In vitro cardiogenesis can be initiated in human CD34+cells. Indian Heart J 60:95–100
Sutherland DR, Anderson L, Keeney M, Nayar R, Chin-Yee I (1996) The ISHAGE guidelines for CD34+cell determination by flow cytometry. International Society of Hematotherapy and Graft Engineering. J Hematother 5:213–226
Srikanth L, Sunitha MM, Venkatesh K, Kumar PS, Chandrasekhar C, Vengamma B, Sarma PV (2015) Anaerobic Glycolysis and HIF1α expression in haematopoietic stem cells explains its quiescence nature. J Stem Cells 10:97–106
Ryseff JK, Bohn AA (2012) Detection of alkaline phosphatase in canine cells previously stained with Wright-Giemsa and its utility in differentiating osteosarcoma from other mesenchymal tumors. Vet Clin Pathol. doi:10.1111/j.1939-165X.2012.00445.x
Srikanth L, Venkatesh K, Sunitha MM, Kumar PS, Chandrasekhar C, Vengamma B, Sarma PV (2016) In vitro generation of type-II pneumocytes can be initiated in human CD34+ stem cells. Biotechnol Lett 38:237–242
Woo MA, Kim MI, Jung JH, Park KS, Seo TS, Park HG (2013) A novel colorimetric immunoassay utilizing the peroxidase mimicking activity of magnetic nanoparticles. Int J Mol Sci 14:9999–10014
Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25:402–408
Kim N, Takami M, Rho J, Josien R, Choi Y (2002) A novel member of the leukocyte receptor complex regulates osteoclast differentiation. J Exp Med 195:201–209
Hamidouche Z, Haÿ E, Vaudin P, Charbord P, Schüle R, Marie PJ, Fromigué O (2008) FHL2 mediates dexamethasone-induced mesenchymal cell differentiation into osteoblasts by activating Wnt/beta-catenin signalingdependent Runx2 expression. Faseb J 22:3813–3822
Hong D, Chen HX, Xue Y, Li DM, Wan XC, Ge R, Li JC (2009) Osteoblastogenic effects of dexamethasone through upregulation of TAZ expression in rat mesenchymal stem cells. J Steroid Biochem Mol Biol 116:86–92
Phillips JE, Gersbach CA, Wojtowicz AM, García AJ (2006) Glucocorticoid-induced osteogenesis is negatively regulated by Runx2/Cbfa1 serine phosphorylation. J Cell Sci 119:581–591
Vater C, Kasten P, Stiehler M (2011) Culture media for the differentiation of mesenchymal stromal cells. Acta Biomater 7:463–477
Franceschi RT, Iyer BS (1992) Relationship between collagen synthesis and expression of the osteoblast phenotype in MC3T3-E1 cells. J Bone Miner Res 7:235–246
Xiao G, Gopalakrishnan R, Jiang D, Reith E, Benson MD, Franceschi RT (2002) Bone morphogenetic proteins, extracellular matrix, and mitogen-activated protein kinase signaling pathways are required for osteoblast-specific gene expression and differentiation in MC3T3-E1 cells. J Bone Miner Res 17:101–110
Tada H, Nemoto E, Foster BL, Somerman MJ, Shimauchi H (2011) Phosphate increases bone morphogenetic protein-2 expression through cAMPdependent protein kinase and ERK1/2 pathways in human dental pulp cells. Bone 48:1409–1416
Pozzobon M, Piccoli M, Ditadi A, Bollini S, Destro R, André-Schmutz I, Masiero L, Lenzini E, Zanesco L, Petrelli L, Cavazzana-Calvo M, Gazzola MV, De Coppi P (2009) Mesenchymal stromal cells can be derived from bone marrow CD133+ cells: implications for therapy. Stem Cells Dev 18:497–510
Acknowledgments
We sincerely acknowledge Sri Venkateswara Institute of Medical Sciences (SVIMS University), India for providing funds to carry out the work. This paper forms a part of Ph. D. thesis work going to be submitted to SVIMS University, Tirupati, Andhra Pradesh, India.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare no financial or commercial conflict of interest.
Rights and permissions
About this article
Cite this article
Srikanth, L., Sunitha, M.M., Kumar, P.S. et al. Gel based in vitro 3D model exploring the osteocytic potentiality of human CD34+ stem cells. Mol Biol Rep 43, 1233–1242 (2016). https://doi.org/10.1007/s11033-016-4053-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11033-016-4053-4